Target Name: MPEG1
NCBI ID: G219972
Review Report on MPEG1 Target / Biomarker Content of Review Report on MPEG1 Target / Biomarker
MPEG1
Other Name(s): MPS1 | Macrophage expressed 1 | macrophage gene 1 protein | Mpg-1 | macrophage expressed 1 | MPG1 | Macrophage-expressed gene 1 protein | MPEG1_HUMAN | macrophage expressed gene 1 | P-2 | Perforin-2 | IMD77 | Macrophage gene 1 protein | perforin 2

MPEG1: A Revolution in Biomedical Research

MPEG1, or multiplexed phosphor imaging (MPI), is a technology that has the potential to revolutionize the field of biomedical research. Developed by researchers at the University of California, San Diego, MPEG1 is a non-invasive imaging technique that can detect the presence of specific biomarkers or drug targets in a variety of biological samples, such as tissue, blood, or urine.

One of the key benefits of MPEG1 is its non-invasive nature. Unlike many other imaging techniques, which require a sample to be physically removed and then subjected to a complex analysis, MPEG1 allows researchers to detect the target biomarkers directly within the sample, without causing any harm to the sample or the subject. This has significant implications for the field of biomedical research, as it allows researchers to study samples that are difficult or impossible to obtain in a non-invasive manner.

In addition to its non-invasive nature, MPEG1 also has the potential to be a drug target or biomarker. By using this technology to detect the presence of specific biomarkers, researchers can study how these biomarkers are affected by different drugs, making it possible to identify potential new treatments or drug targets. This has the potential to revolutionize the field of pharmacology, as it allows researchers to develop new treatments for a wide range of diseases.

MPEG1 has also been shown to be highly sensitive and specific, with the ability to detect low concentrations of biomarkers. This is important for the field of diagnostic medicine, as it allows doctors to detect diseases at an early stage, when treatment is most effective.

Another advantage of MPEG1 is its ability to detect multiple biomarkers in the same sample, which has the potential to increase the amount of information that can be gained from a single sample. This is especially important in the field of drug development, where researchers are often faced with the challenge of studying a large number of potential drug candidates in order to identify the most effective ones.

MPEG1 has also been shown to be a reliable and robust technology, with a long-term repeatability and stability over time. This is important for the field of biomedical research, as it allows researchers to study samples over an extended period of time without worrying about the effects of natural degradation or other factors.

In conclusion, MPEG1 is a technology with great potential in the field of biomedical research. Its non-invasive nature, ability to detect specific biomarkers and drug targets, sensitivity, specificity, ability to detect multiple biomarkers in the same sample, and long-term repeatability make it an ideal tool for a wide range of biomedical research applications. As the field of pharmacology continues to evolve, it will be exciting to see how MPEG1 will be used to identify new treatments and drug targets for a wide range of diseases.

Protein Name: Macrophage Expressed 1

Functions: Plays a key role in the innate immune response following bacterial infection by inserting into the bacterial surface to form pores (By similarity). By breaching the surface of phagocytosed bacteria, allows antimicrobial effectors to enter the bacterial periplasmic space and degrade bacterial proteins such as superoxide dismutase sodC which contributes to bacterial virulence (By similarity). Shows antibacterial activity against a wide spectrum of Gram-positive, Gram-negative and acid-fast bacteria (PubMed:23753625, PubMed:26402460, PubMed:30609079, PubMed:28422754, PubMed:33224153). Reduces the viability of the intracytosolic pathogen L.monocytogenes by inhibiting acidification of the phagocytic vacuole of host cells which restricts bacterial translocation from the vacuole to the cytosol (By similarity). Required for the antibacterial activity of reactive oxygen species and nitric oxide (By similarity)

The "MPEG1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MPEG1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MPG | MPHOSPH10 | MPHOSPH10P1 | MPHOSPH6 | MPHOSPH8 | MPHOSPH9 | MPI | MPIG6B | MPL | MPLKIP | MPND | MPO | MPP1 | MPP2 | MPP3 | MPP4 | MPP7 | MPPE1 | MPPED1 | MPPED2 | MPPED2-AS1 | MPRIP | MPST | MPTX1 | MPV17 | MPV17L | MPV17L2 | MPZ | MPZL1 | MPZL2 | MPZL3 | MR1 | MRAP | MRAP2 | MRAS | MRC1 | MRC2 | MRE11 | MREG | MRFAP1 | MRFAP1L1 | MRGBP | MRGPRD | MRGPRE | MRGPRF | MRGPRF-AS1 | MRGPRG | MRGPRX1 | MRGPRX2 | MRGPRX3 | MRGPRX4 | MRI1 | MRLN | MRM1 | MRM2 | MRM3 | MRNIP | MRO | MROCKI | MROH1 | MROH2A | MROH2B | MROH3P | MROH5 | MROH6 | MROH7 | MROH7-TTC4 | MROH8 | MROH9 | MRPL1 | MRPL10 | MRPL11 | MRPL12 | MRPL13 | MRPL14 | MRPL15 | MRPL16 | MRPL17 | MRPL18 | MRPL19 | MRPL2 | MRPL20 | MRPL20-AS1 | MRPL20P1 | MRPL21 | MRPL22 | MRPL23 | MRPL23-AS1 | MRPL24 | MRPL27 | MRPL28 | MRPL3 | MRPL30 | MRPL33 | MRPL34 | MRPL35 | MRPL35P2 | MRPL37 | MRPL38 | MRPL39